{
    "clinical_study": {
        "@rank": "68911", 
        "acronym": "ESPOIR", 
        "arm_group": {
            "arm_group_label": "Decellularized human valves", 
            "description": "Pulmonary heart valve replacement"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, non-randomized, single-arm, multicentre surveillance study to be\n      conducted in Europe. The Surveillance is designed as a study, where\n\n        -  ESPOIR PV (pulmonary valve) is prescribed in the usual manner in accordance with the\n           terms of the approval.\n\n        -  The assignment of the patient to a particular therapeutic strategy is not decided in\n           advance by this Surveillance Protocol but falls within current practice and the\n           prescription of ESPOIR PV is clearly separated from the decision to include the patient\n           in the Surveillance.\n\n        -  No additional diagnostic or monitoring procedures shall be applied to the patients\n\n        -  and epidemiological methods shall be used for the analysis of collected data.\n\n      Evaluation of decellularized human heart valves for pulmonary heart valve replacement in\n      comparison to current valve substitutes. Safety endpoints include cardiovascular adverse\n      events, time to re-operation, re-intervention and explantation. Efficacy endpoints include\n      freedom from valve dysfunction and hemodynamic performance."
        }, 
        "brief_title": "European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Valve Disease", 
        "condition_browse": {
            "mesh_term": "Heart Valve Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Indication for pulmonary valve replacement according to current medical guidelines in\n             heart disease.\n\n          -  Signed Informed consent of legal guardians or patients, assent of patients.\n\n        Exclusion Criteria:\n\n          -  The patient has not provided Surveillance informed consent.\n\n          -  The patient shall not suffer from\n\n               -  generalized connective tissue disorders (eg, Marfan syndrome), or\n\n               -  active rheumatic disorders, or\n\n               -  severe asymmetric calcification of the valve ring.\n\n          -  The coronary arteries of the patient shall not be in abnormal position or heavily\n             calcified.\n\n          -  Patients shall not show hypersensitivity against Sodium Dodecyl Sulphate (SDS),\n             Sodium Desoxycholate (SDC), human collagen (or other elastic fibers) or Benzonase\u00ae."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with acquired and congenital heart disease requiring heart valve replacement."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02035540", 
            "org_study_id": "Surveillance Protocol 2013-11", 
            "secondary_id": "FP7 2007-2013, No. 278453"
        }, 
        "intervention": {
            "arm_group_label": "Decellularized human valves", 
            "intervention_name": "Decellularized human valves", 
            "intervention_type": "Other", 
            "other_name": "ESPOIR PV"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 13, 2014", 
        "link": {
            "description": "ESPOIR Website", 
            "url": "http://www.espoir-clinicaltrial.eu"
        }, 
        "location": [
            {
                "contact": {
                    "email": "bart.meyns@uzleuven.be", 
                    "last_name": "Bart Meyns, Prof. Dr.", 
                    "phone": "0032-16 34 42 60"
                }, 
                "contact_backup": {
                    "email": "klaartje.vandenbossche@uzleuven.be", 
                    "last_name": "Klaartje Van den Bossche", 
                    "phone": "0032-16 34 21 60"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }, 
                    "name": "Universitair Ziekenhuis Leuven, UZL"
                }, 
                "investigator": {
                    "last_name": "Bart Meyns, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Pascal Vouhe, Prof.", 
                    "phone": "0033 -144381867"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75015"
                    }, 
                    "name": "Universit\u00e9 Paris Descartes, UPD"
                }, 
                "investigator": {
                    "last_name": "Pascale Vouhe, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "sarikouch.samir@mh-hannover.de", 
                    "last_name": "Samir Sarikouch, PD MD", 
                    "phone": "049511532", 
                    "phone_ext": "5567"
                }, 
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30625"
                    }, 
                    "name": "Hannover Medical School"
                }, 
                "investigator": {
                    "last_name": "Axel Haverich, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "giovanni.stellin@unipd.it", 
                    "last_name": "Giovanni Stellin, Prof. Dr.", 
                    "phone": "0039-049 8212427"
                }, 
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy", 
                        "zip": "35128"
                    }, 
                    "name": "Universit\u00e0 degli studi di Padova, Azienda Ospedaliera di Padova, UNIPD/AOP"
                }, 
                "investigator": [
                    {
                        "last_name": "Giovanni Stellin, Prof. Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Massimo Padalino, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chisinau", 
                        "country": "Moldova, Republic of", 
                        "zip": "2004"
                    }, 
                    "name": "Universitatea de Stat de Medicina si Farmacie \"Nicolae Testemitanu\", SMPHU"
                }, 
                "investigator": {
                    "last_name": "Anatol Ciubotaru, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "m.g.hazekamp@lumc.nl", 
                    "last_name": "Mark G Hazekamp, Prof. Dr.", 
                    "phone": "0031-31 71 526 2348"
                }, 
                "facility": {
                    "address": {
                        "city": "Leiden", 
                        "country": "Netherlands", 
                        "zip": "2333"
                    }, 
                    "name": "Leids Universitair Medisch Centrum, LUMC"
                }, 
                "investigator": {
                    "last_name": "Mark G Hazekamp, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Hitendu.dave@kispi.uzh.ch", 
                    "last_name": "Hitendu Dave, Dr.", 
                    "phone": "0041-44 2668002"
                }, 
                "facility": {
                    "address": {
                        "city": "Zuerich", 
                        "country": "Switzerland", 
                        "zip": "8032"
                    }, 
                    "name": "Universitaet Zuerich, UZH, Switzerland"
                }, 
                "investigator": [
                    {
                        "last_name": "Michael H\u00fcbler, Prof. Dr.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Hitendu Dave, Dr.", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "tsangv@gosh.nhs.uk", 
                    "last_name": "Victor Tsang", 
                    "phone": "0044-20-7813-8159"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "WC1N 3JH"
                    }, 
                    "name": "Great Ormond Street Hospital for Children NHS Trust, GOSH"
                }, 
                "investigator": {
                    "last_name": "Victor Tsang", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "France", 
                "Germany", 
                "Italy", 
                "Moldova, Republic of", 
                "Netherlands", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR", 
        "overall_contact": {
            "email": "sarikouch.samir@mh-hannover.de", 
            "last_name": "Samir Sarikouch, PD MD", 
            "phone": "049511532", 
            "phone_ext": "5567"
        }, 
        "overall_official": [
            {
                "affiliation": "Hannover Medical School", 
                "last_name": "Axel Haverich, Prof. Dr.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hannover Medical School", 
                "last_name": "Samir Sarikouch, PD Dr.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Paul-Ehrlich-Institut", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Cardiovascular Adverse Reactions; Serious Adverse Reactions, such as infections, immunological reactions, etc.", 
                "measure": "Amount of SARs (serious adverse reactions)", 
                "safety_issue": "Yes", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "Freedom from valve dysfunction leading to re-intervention or explantation at end of the study.", 
                "measure": "Freedom from valve dysfunction", 
                "safety_issue": "No", 
                "time_frame": "up to 24 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02035540"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Blood Parameters as additional safety data to support presence/absence of Adverse Reactions", 
                "measure": "Blood Parameters", 
                "safety_issue": "Yes", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "Diameters of ESPOIR PV at end of the study in comparison to diameters at implantation", 
                "measure": "Diameters of ESPOIR PV at end of the study", 
                "safety_issue": "No", 
                "time_frame": "after 24 months"
            }, 
            {
                "description": "Time to reoperation due to explantation", 
                "measure": "Time to reoperation", 
                "safety_issue": "Yes", 
                "time_frame": "up to to 24 months"
            }, 
            {
                "description": "Time to death", 
                "measure": "Time to death", 
                "safety_issue": "Yes", 
                "time_frame": "up to 24 months"
            }, 
            {
                "description": "valve competence assessed by noninvasive imaging tools such as echocardiography or cardiac magnetic resonance imaging", 
                "measure": "Evaluation of transvalvular gradients", 
                "safety_issue": "No", 
                "time_frame": "up to 24 months"
            }
        ], 
        "source": "corlife", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Hannover Medical School", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "State University of Medicine and Pharmaceutics, Chisinau, Moldavia", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Leiden University Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Great Ormond Street Hospital for Children NHS Foundation Trust", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Padova", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "H\u00f4pital Necker-Enfants Malades", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Zurich", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Universitaire Ziekenhuizen Leuven", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "German Society for Tissue Transplantation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "European Homograft Bank, Belgium", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Gottfried Wilhelm Leibniz Universit\u00e4t Hannover", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "corlife", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}